News
FDA APPROVED THE MEDICATION FOR SKIN ITCHING ASSOCIATED WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS.ADVANCES IN TYPE 2 DIABETES MANAGEMENT IN CHILDREN.FIRST ORAL MEDICATION FOR THE TREATMENT OF CHILDREN WITH MULTIPLE SCLEROSIS WAS APPROVED.THE WORLD'S FIRST MEDICATION FOR THE TREATMENT O...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Union of pediatricians of Russia
2021-10-01
|
| Series: | Педиатрическая фармакология |
| Online Access: | https://www.pedpharma.ru/jour/article/view/2055 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | FDA APPROVED THE MEDICATION FOR SKIN ITCHING ASSOCIATED WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS.ADVANCES IN TYPE 2 DIABETES MANAGEMENT IN CHILDREN.FIRST ORAL MEDICATION FOR THE TREATMENT OF CHILDREN WITH MULTIPLE SCLEROSIS WAS APPROVED.THE WORLD'S FIRST MEDICATION FOR THE TREATMENT OF SHORT BOWEL SYNDROME WAS REGISTERED IN RUSSIAN FEDERATION. |
|---|---|
| ISSN: | 1727-5776 2500-3089 |